“…Following the hypothesis that the pathway leading from behavior to CHD is the chronic sympathetic nervous system arousal accompanying chronic Type A hyperreactivity (1), targets of treatment were to reduce the frequency, intensity, and duration of physiologic (2)(3)(4)(5)(6)(7), cognitive (4)(5)(6)(7), and/or behavioral (2,6) hyperreactivity. The most common research design evaluated the effectiveness with which a variety of therapeutic approaches [e.g., physical relaxation (2)(3)(4)(5)(6), cognitive self-instruction (7), insight (4,5), group support (6)] reduced Type A hyperreactivity in small groups of subjects (from 14 to 42) over short periods of time (from 5 to 14 hr). Reductions in the type A behavior pattern (TABP) were assessed using Type A questionnaires [e.g., the Jenkins Activity Survey (3)(4)(5)(6), the Framingham Type A Behavior Scale (6), the Bortner Type A Rating Scale (7), Type A components questionnaires (e.g., the Novaco Anger Scale (6), the Thurstone Adjective Checklist (6)], and measures of psychologic distress [e.g., the State-Trait Anxiety Inventory (3,5)].…”